Articles by Michelle Hoffman - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Michelle Hoffman

Passion, Innovation, and Loss

At a time when the industry is struggling with innovation, it might do well to learn a lesson from a few great innovators.
Nov 1, 2011

At a time when the industry is struggling with innovation, it might do well to learn a lesson from a few great innovators.

Retrospection and Introspection at FDA

A report commissioned by FDA evaluates the QbD paradigm.
Sep 1, 2011

A report commissioned by FDA evaluates the QbD paradigm.

Biosimilars or Bust

Are biosimilars the next big thing or just the next big bubble?
Aug 1, 2011

Are biosimilars the next big thing or just the next big bubble?

Legislation v. Litigation

Which route will we take to arrive at a national stem-cell policy?
Jul 1, 2011

Which route will we take to arrive at a national stem-cell policy?

Perception and Reality

Those who doubt there's faith in science, should check out our annual Bioprocessing Survey.
May 1, 2011

Those who doubt there's faith in science, should check out our annual Bioprocessing Survey.

Research and Development Headed for Divorce

Research and development headed for divorce.
Apr 1, 2011

Research and development headed for divorce.

What a Piece of Work is Pharma

Capable of great works, pharma too often yields to the lesser angels of its nature
Feb 1, 2011

Capable of great works, pharma too often yields to the lesser angels of its nature

Following on Follow-Ons

So often a leader on the world stage, the US is a laggard when it comes to regulating follow-on biologics.
Jan 1, 2011

So often a leader on the world stage, the US is a laggard when it comes to regulating follow-on biologics.

ADVERTISEMENT

ADVERTISEMENT

Click here